Specifically, whereas homozygous male carriers of the UGT2B15*2 variant had a lesser reduction in anxiety compared to placebo, female patients with the same genotype experienced greater anxiety reduction due to lorazepam premedication [132]. The gene discussed is UGT2B15; the disease is Anxiety.